What You Should Know:
- Qualified Health today announced its launch with $30 million in seed funding to develop the infrastructure for generative AI in healthcare.
- The major investors are SignalFire, Healthier Capital, Town Hall Ventures, and Frist Cressey Ventures, along with participation from Intermountain Ventures, Flare Capital Partners, and prominent healthcare and technology sector angels.
Qualified Health Launches Comprehensive Generative AI Platform to Revolutionize
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Deciphex Secures $32.3M for AI-Powered Digital Pathology
What You Should Know:
- Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories (NYSE: CRL), IRRUS Investments, HBAN Medtech Syndicate and Nextsteps Capital, the funding will advance Deciphex's mission to democratize access to high-quality
Read More
PHTI Launches AI Taskforce to Improve Healthcare Efficiency
What You Should Know:
- The Peterson Health Technology Institute (PHTI) announced the formation of an Artificial Intelligence (AI) Taskforce dedicated to evaluating and improving the administrative performance of AI technologies in healthcare.
- The initiative brings together leaders from major U.S. health systems, AI solution providers, and industry experts to address the growing need for efficient and effective AI implementation in healthcare operations.
Focus on Operational
Read More
Innovaccer Secures $275M to Accelerate AI Innovation in Healthcare
What You Should Know:
- Innovaccer Inc., a healthcare AI company, announced today a $275M Series F funding round.
- The latest investment, combined with primary and secondary funding, includes participation from prominent investors such as B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.
Focus on AI-Powered Solutions
Innovaccer plans to introduce multiple AI copilots and agents to its comprehensive suite of
Read More
Q/A: Cedar Exec Talks The Untapped Potential of AI in Healthcare Call Centers in 2025
What if AI could dramatically reduce call volume, improve patient satisfaction, and empower your call center staff? In this exclusive interview, Dugan Winkie, Head of Commercial Strategy at Cedar, sheds light on the often-overlooked opportunity of leveraging AI in healthcare call centers.
Winkie explores the unique challenges and opportunities AI presents for providers, highlighting the potential for increased efficiency, improved patient experiences, and significant financial gains. He
Read More
The RCM Arms Race: How AI is Reshaping Healthcare Finance in 2025
As healthcare providers head into 2025, a technological arms race is reshaping revenue cycle management (RCM), with artificial intelligence (AI) emerging as the decisive factor between financial success and struggle. With approximately 46% of hospitals and health systems already utilizing AI in their RCM operations, the industry stands at a critical juncture where matching payer sophistication has become imperative for survival. This transformation represents a fundamental shift in how
Read More
Pepticom Secures $6.6M to Advance AI-Powered Peptide Drug Discovery
What You Should Know:
- Pepticom, an innovator in AI-driven peptide-based therapeutics secures $6.6M in a Series A1 funding round led by Japan Israel High Tech Ventures 2 LP, with strong support from existing investors.
- The new funding will accelerate the development of Pepticom's oral IL-17 inhibitor program, focusing on creating improved treatments for autoimmune diseases like psoriasis and psoriatic arthritis.
Revolutionizing Autoimmune Disease Treatment
Pepticom is
Read More
M&A: Predictive Oncology to be Acquired by Renovaro
What You Should Know:
- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced its upcoming acquisition by Renovaro, Inc. (NASDAQ: RENB) in a strategic move aimed at accelerating innovation and improving cancer treatment outcomes.
- The merger brings together two companies with a shared commitment to leveraging artificial intelligence and machine learning to transform cancer care.
Synergistic Strengths and Shared Vision
Both Predictive
Read More
AI Can Make Plastic Surgery Practices More Human
Eye contact and good desk-side manner have always been incredibly important in the plastic surgery specialty, where patients’ decisions can be heavy with emotion around the perception of their image. Even what some see as a “small touchup” like dermal fillers are huge decisions for others because it is a change in how they present themselves physically and then carry themselves emotionally.
The practice of plastic surgery is inherently human, in the most sentimental sense. But, as we
Read More
Why Healthcare Execs are Hesitant to Embrace Long-Term AI Contracts
AI promises significant advances in patient care and healthcare operations, from improved diagnostics and personalized treatments plans to streamlining administrative tasks. Yet, a clear pattern has emerged in the decisions healthcare technology leaders are making around AI adoption within their organizations. Leaders are grappling with how to balance cutting-edge innovation with the risks and complexities of adopting an AI solution.
Despite the enormous potential of AI, healthcare executives
Read More
